Status | Study |
Completed |
Study Name: Phase II Dose Finding Study of RDEA3170 Versus Placebo in Japanese Patients With Gout or Asymptomatic Hyperuricemia Condition: Gout and Hyperuricemia Date: 2014-02-26 Interventions: Drug: RDEA3170 Oral Treatment |
Active, not recruiting |
Study Name: Febuxostat for Cerebral and caRdiorenovascular Events prEvEntion stuDy Condition: Hyperuricemia Date: 2013-10-30 Interventions: Drug: Febuxostat Febuxostat will be taken once daily after |
Recruiting |
Study Name: Study of Levotofisopam 50 mg Three Times a Day (TID) Administered for 7 Days on Hyperuricemia and Gout Condition: Hyperuricemia Gout Date: 2012-01-24 Interventions: Drug: levotofisopam 50 mg on Day 1, 50 mg TID on Days 2 through 6, and a single dose of 50 mg on Day 7 |
Completed |
Study Name: Open Label Safety/Efficacy Study of Arhalofenate in Combination With Febuxostat for Hyperuricemia in Gout Patients Condition: Hyperuricemia Gout Date: 2011-08-11 Interventions: Drug: Arhalofenate 400 mg once |
Completed |
Study Name: Safety and Efficacy Study of MBX-102 in Treatment of Hyperuricemia in Patients With Gout Condition: Hyperuricemia Gout Date: 2011-04-14 Interventions: Drug: Arhalofenate Arhalofenat |
Completed |
Study Name: Study of Tranilast Alone or in Combination With Allopurinol in Subjects With Hyperuricemia Condition: Gout Hyperuricemia Date: 2010-01-05 Interventions: Drug: Tranilast Tranilast tabl |
Completed |
Study Name: Study of Tranilast Alone or in Combination With Febuxostat in Patients With Hyperuricemia Condition: Gout Hyperuricemia Date: 2009-10-06 Interventions: Drug: Tranilast Tranilast tabl |
Completed |
Study Name: Gout Dose Response Study Condition: Hyperuricemia Date: 2009-08-07 Interventions: Drug: RDEA594 Uricosuric agent |
Completed |
Study Name: Safety and Efficacy of TULY (Rasburicase) in Prevention and Treatment of Malignancy-associated Hyperuricemia Condition: Hyperuricemia Date: 2009-05-23 Interventions: Drug: TULY TULY (rasburicase) 0.20 mg/kg body weight intravenously for 4 days |
Completed |
Study Name: A Study of RDEA806 in Hyperuricemic Subjects With Symptomatic Gout Condition: Hyperuricemia Date: 2008-08-25 Interventions: Drug: RDEA806 Uricosuric agent |